Press release
Europe T Cell Therapy Market Global Rising Demand & Huge Scope Till 2030
Europe T Cell Therapy Market is growing at a CAGR of 16.3% to reach US$ 2,345.49 million by 2030 from US$ 699.24 million in 2022 by Modality, Therapy Type, and Indication. At 16.3% CAGR, the Europe T Cell Therapy Market is Projected to be Worth US$ 2,345.49 million by 2030, says Business Market InsightsGet PDF Sample Report + All Related Table and Graphs @: https://www.premiummarketinsights.com/sample/BMIRE00029308?utm_source=OpenPR&utm_medium=10823
Competitive Landscape: Europe T Cell Therapy Market:
According to Business Market Insights' research, the Europe T cell therapy market was valued at US$ 699.24 million in 2022 and is expected to reach US$ 2,345.49 million by 2030, registering a CAGR of 16.3% from 2022 to 2030. Growing burden of cancer worldwide and increasing number of approvals of t-cell therapies are among the critical factors attributed to the Europe T cell therapy market expansion. Globally, companies operating in the T-cell therapy market focus on strategic developments such as collaborations, expansions, agreements, and investment, which help them improve their sales, expand their geographic reach, and enhance their capacities to cater to a larger than existing customer base. A few noteworthy developments in the T-cell therapy market are mentioned below.In August 2023, Astellas invested US$ 50 million in Poseida's CAR T-cell therapy. Astellas will have exclusive negotiation and first refusal for licensing P-MUC1C-ALLO1 in solid tumors as part of the agreement. P-MUC1C-ALLO1 is an allogeneic CAR T-cell therapy targeting cancer-specific Mucin 1 protein (MUC1-C) forms. It is currently under investigation in an open-label multicentre Phase I clinical trial (NCT05239143) treating multiple epithelial-derived solid tumor indications. In May 2023, Laurus Labs' stake in ImmunoACT will now increase to 33.86% on a fully diluted basis post completion of the deal. The company had already acquired 26.62% of stakes in ImmunoACT in November 2021. ImmunoACT has a portfolio of CAR T-cell therapy assets under various development stages for treating multiple autoimmune diseases and oncology indications. This investment further strengthens Laurus Labs' commitment to accessing novel Cell and Gene Therapy technology and enhances its affordability for patients. This investment will further help ImmunoACT to gear up for the manufacture of more treatments
Bristol-Myers Squibb Co
Gilead Sciences Inc
Immunocore Holdings Plc
Innovent Biologics Inc
Janssen Global Services LLC
Legend Biotech Corp
Novartis AG
Bottom of Form
Chapter Details of Europe T Cell Therapy Market:
Part 01: Executive Summary
Part 02: Scope of The Report
Part 03: Europe T Cell Therapy Market Landscape
Part 04: Europe T Cell Therapy Market Sizing
Part 05: Europe T Cell Therapy Market Segmentation by Product
Part 06: Five Forces Analysis
Part 07: Customer Landscape
Part 08: Geographic Landscape
Part 09: Decision Framework
Part 10: Drivers and Challenges
Part 11: Market Trends
Part 12: Vendor Landscape
Part 13: Vendor Analysis
Interested in Purchasing this Report? Click here @ https://www.premiummarketinsights.com/buy/BMIRE00029308?utm_source=OpenPR&utm_medium=10823
Contact Us:
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Sonam Patil
SE-mail: sales@permiummarketinsights.com
Phone: +1-646-491-9876
About Us:
Bussiness Market Insights is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost effective research reports and solutions from various publishers.
The market research industry has changed in last decade. As corporate focus has shifted to niche markets and emerging countries, a number of publishers have stepped in to fulfil these information needs. We have experienced and trained staff that helps you navigate different options and lets you choose best research solution at most effective cost.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Europe T Cell Therapy Market Global Rising Demand & Huge Scope Till 2030 here
News-ID: 3853923 • Views: …
More Releases from Business Market Insights
Step by Step Ultimate Guide to Wire Harness :(PDF)
The Europe wire harness market is expected to grow from US$ 21,759.33 million in 2023 to US$ 33,154.13 million by 2030. It is estimated to grow at a CAGR of 6.2% from 2023 to 2030.
Download PDF➜ https://www.businessmarketinsights.com/sample/BMIRE00027213?utm_source=Openpr&utm_medium=10694
Automobile manufacturers are implementing various technologies in their upcoming models to stay competitive in the market. Technologies such as automatic high beam control, self-driving, cruise control, and automatic lift gates are highly…
Europe Automotive Transceivers Market Analysis, Share, Trend, Industry Report Fo …
The Europe automotive transceivers market is expected to grow from US$ 1,587.45 million in 2022 to US$ 2,283.04 million by 2028. It is estimated to grow at a CAGR of 6.2% from 2022 to 2028.
The growing regulatory support for zero-emission vehicles in different countries through subsidies and tax rebates encourages the manufacturing and adoption of electric vehicles. EV sales also grew strongly in Europe by 65% to reach 2.3 million…
Europe Granular Biochar Market Analysis, Share, Trend, Industry Report Forecast …
The Europe granular biochar market is expected to grow from US$ 2.10 Million in 2022 to US$ 4.04 Million by 2028. It is estimated to grow at a CAGR of 11.6% from 2022 to 2028.
Agriculture is one of the major areas of application for granular biochar. In recent years, the interest in using biochar in agriculture has been increasing due to its beneficial properties of this material. The application of…
Europe Biosimilars Market Revenue to Cross US$ 10,344.86 million by 2030: Busine …
The Europe biosimilars market is expected to grow from US$ 10,344.86 million in 2022 to US$ 1,15,125.91 million by 2030; it is estimated to grow at a CAGR of 35.1% from 2022 to 2030
Get PDF Sample Report + All Related Table and Graphs @: https://www.businessmarketinsights.com/sample/BMIRE00028358?utm_source=OpenPR&utm_medium=10823
Competitive Landscape: Europe Biosimilars Market:
The report highlights trends prevailing in the market and factors driving the market growth. The market growth is attributed to the increasing…
More Releases for Europe
Strategy Consulting Market 2025 | Analysis By Top Key Players: Booz & Co. , Rola …
Global Strategy Consulting Market 2019-2025, has been prepared based on an in-depth market analysis with inputs from industry experts. This report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
The key players covered in this study
McKinsey , The Boston Consulting Group , Bain & Company , Booz & Co. , Roland Berger Europe…
Influenza Vaccination Market Global Forecast 2018-25 Estimated with Top Key Play …
UpMarketResearch published an exclusive report on “Influenza Vaccination market” delivering key insights and providing a competitive advantage to clients through a detailed report. The report contains 115 pages which highly exhibits on current market analysis scenario, upcoming as well as future opportunities, revenue growth, pricing and profitability. This report focuses on the Influenza Vaccination market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This…
Global Strategy Consulting Market Research Report 2018-2025 | Global Key Player …
An up-to-date research report has been disclosed by Market Research Hub highlighting the title “Global Strategy Consulting Market Size, Status and Forecast 2018-2025” which provides an outlook for current market value as well as the expected growth of Strategy Consulting during 2018-2025. The report studies the casing heads market worldwide, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, size, growth, revenue, consumption, import and export…
Strategy Consulting Market Deep Insights with Core Business Strategies 2018 - Ro …
Strategy Consulting Market report provides a vital recent industry data which covers in general market situation along with future scenario for industry around the Globe. It also consist of major data along with forecasts of a global market along with clear presentation of diagrams (charts and tables).
Global strategy consulting market size status and forecast 2025 has a vast collection of market research reports concerning the software industry, its sub-sectors, and…
Wearable Heart Monitoring Devices Market 2018 To 2023 – Top Leaders Beurer Gmb …
The Worldwide Wearable Heart Monitoring Devices Market is growing at a healthy rate. The major players in this market are Medtronic (U.S.), Kinetec Products UK Ltd. (South America), Beurer GmbH (Europe), Medisana AG (Europe), Briggs Healthcare (U.S.), Polar Electro (Europe), SUUNTO (Europe), Koninklijke Philips N.V. (Europe), Garmin Ltd. (Europe) and others. The Wolrdwide Wearable Heart Monitoring devices is segmented on the basis of products, type, application, and end users. On…
Surgical Equipment Market 2018 Leading Manufacturer in Europe, the Middle East & …
The Europe, the Middle East & Africa Surgical Equipment Market is expected to grow at an approximate CAGR of 6.7% during the forecast period.
A surgical equipment is a designed tool or device to carry out various surgical procedures so as to modifying biological tissues and to provide access for viewing them. The surgical equipment can be designed specifically for a particular surgery or it can be used as general purpose…
